文献速递瓣膜外科

快速释放或无缝线生物瓣与常规生物瓣主动脉瓣置换的Meta分析

Rapid deployment or sutureless versus conventional bioprosthetic aortic valve replacement: A meta-analysis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-02-13

这项Meta分析纳入21篇文章(快速释放或无缝线瓣组1297例,常规生物瓣组1488例),比较两组主动脉瓣置换的早期和随访结局。结果显示快速释放或无缝线瓣组主动脉阻断时间和体外循环时间显著更短,但任何瓣周漏和永久起搏器植入风险显著更高,早期死亡和随访全因死亡无显著差异。

要点

  • 快速释放或无缝线瓣组主动脉阻断时间和体外循环时间显著短于常规生物瓣组。
  • 快速释放或无缝线瓣组任何瓣周漏和永久起搏器植入风险显著高于常规生物瓣组。
  • 两组早期死亡和随访全因死亡风险无显著差异。

核心结论

  • 快速释放或无缝线主动脉瓣置换的主动脉阻断时间和体外循环时间显著短于常规生物瓣主动脉瓣置换,但这一差异未转化为术后结局、早期死亡和随访全因死亡的改善。
  • 植入快速释放或无缝线瓣时可能需要谨慎,因为无论快速释放或无缝线瓣类型如何,其与更高的永久起搏器植入发生率相关。

研究设计与样本

  • 这项Meta分析检索了5个在线数据库,纳入21篇文章,快速释放或无缝线瓣组1297例患者,常规生物瓣组1488例患者。
  • 主要结局为术后并发症,次要结局包括主动脉阻断时间、体外循环时间、早期死亡和随访全因死亡。

主要发现

  • 快速释放或无缝线瓣组主动脉阻断时间较常规生物瓣组显著缩短(均数差-26.34;95%CI -31.86至-20.82)。
  • 快速释放或无缝线瓣组体外循环时间较常规生物瓣组显著缩短(均数差-25.33;95%CI -30.79至-19.87)。
  • 快速释放或无缝线瓣组任何瓣周漏风险显著高于常规生物瓣组(RR 2.32;95%CI 1.53-3.51)。
  • 快速释放或无缝线瓣组永久起搏器植入风险显著高于常规生物瓣组(RR 2.08;95%CI 1.49-2.90)。
  • 快速释放或无缝线瓣组瓣周漏≥2级风险与常规生物瓣组无显著差异(RR 2.05;95%CI 0.71-5.93)。

临床怎么用

  • 作者认为,快速释放或无缝线瓣的主动脉阻断时间和体外循环时间显著短于常规生物瓣,但这一差异未转化为术后结局、早期死亡和随访全因死亡的改善。
  • 作者认为,植入快速释放或无缝线瓣时可能需要谨慎,因为无论快速释放或无缝线瓣类型如何,其与更高的永久起搏器植入发生率相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This meta-analysis was conducted to compare the early and follow-up outcomes of aortic valve replacement using rapid deployment or sutureless (RD) valves (RDAVR group) with aortic valve replacement using conventional bioprostheses (CAVR group). METHODS: A literature search of 5 online databases was conducted. The primary outcomes were postoperative complications and the secondary outcomes included the aortic cross-clamp (ACC) and cardiopulmonary bypass (CPB) times and early mortality and all-cause mortality during follow-up. RESULTS: Twenty-one articles (RDAVR group = 1297 patients; CAVR group = 1488 patients) were selected. The pooled analyses showed that the ACC and CPB times were significantly shorter in the RDAVR group than in the CAVR group (mean difference, -26.34; 95% confidence interval [CI], -31.86 to -20.82 and mean difference, -25.33; 95% CI, -30.79 to -19.87, respectively). The pooled risk ratios (RRs) of any paravalvular leak and permanent pacemaker (PPM) insertion were significantly higher in the RDAVR group than in the CAVR group (RR, 2.32; 95% CI, 1.53-3.51 and RR, 2.08; 95% CI, 1.49-2.90, respectively). The pooled analysis showed that the risk of a paravalvular leak grade ≥2 in the RDAVR group did not significantly differ between the RDAVR and CAVR groups (RR, 2.05; 95% CI, 0.71-5.93). The risk of PPM insertion remained significant when only studies reporting adjusted outcomes were pooled. The risks of other postoperative complications, early mortality, and all-cause mortality during follow-up were not significantly different between the RDAVR and CAVR groups. CONCLUSIONS: RDAVR is associated with significantly shorter ACC and CPB times than CAVR, although this difference did not translate into improved postoperative outcomes, early mortality, and all-cause mortality during follow-up. Care might be needed when implanting RD valves because they are associated with a higher incidence of PPM insertion, regardless of the RD valve type.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sohn SH, Jang MJ, Hwang HY, et al. Rapid deployment or sutureless versus conventional bioprosthetic aortic valve replacement: A meta-analysis. J Thorac Cardiovasc Surg. 2018. PMID: 29548584. doi:10.1016/j.jtcvs.2018.01.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。